EVR Research Acquires New Position in Ingevity
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy NGVT?
Source: Fool
- New Investment Position: On February 17, 2026, EVR Research disclosed to the SEC that it initiated a new position in Ingevity by acquiring 100,000 shares worth $5.92 million, indicating strong confidence in the company.
- Asset Allocation Insight: The newly acquired shares represent 3.19% of EVR Research's reportable U.S. equity assets totaling $185.31 million, highlighting the fund's strategic emphasis on Ingevity within its portfolio.
- Strong Market Performance: As of now, Ingevity shares are priced at $68.56, reflecting a 56% increase over the past year, significantly outperforming the S&P 500's approximate 19% gain, showcasing its robust market position.
- Positive Industry Outlook: Ingevity's operations are closely tied to emissions standards, infrastructure spending, and industrial production, which are expected to perform well when economic momentum stabilizes, aligning with EVR Research's investment strategy and demonstrating confidence in future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NGVT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NGVT
Wall Street analysts forecast NGVT stock price to fall
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 67.860
Low
60.00
Averages
67.00
High
71.00
Current: 67.860
Low
60.00
Averages
67.00
High
71.00
About NGVT
Ingevity Corporation develops, manufactures and brings to market solutions that help customers solve complex problems and make the world more sustainable. The Company operates in three reporting segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals. The Performance Materials segment manufactures products in the form of powder, granular, extruded pellets, extruded honeycombs, and activated carbon sheets. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. Performance Chemicals includes specialty chemicals and pavement technologies. The Company’s products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
EVR Research Acquires New Position in Ingevity
- New Investment Position: On February 17, 2026, EVR Research disclosed to the SEC that it initiated a new position in Ingevity by acquiring 100,000 shares worth $5.92 million, indicating strong confidence in the company.
- Asset Allocation Insight: The newly acquired shares represent 3.19% of EVR Research's reportable U.S. equity assets totaling $185.31 million, highlighting the fund's strategic emphasis on Ingevity within its portfolio.
- Strong Market Performance: As of now, Ingevity shares are priced at $68.56, reflecting a 56% increase over the past year, significantly outperforming the S&P 500's approximate 19% gain, showcasing its robust market position.
- Positive Industry Outlook: Ingevity's operations are closely tied to emissions standards, infrastructure spending, and industrial production, which are expected to perform well when economic momentum stabilizes, aligning with EVR Research's investment strategy and demonstrating confidence in future growth.
See More
Ingevity Corporation Q4 2025 Earnings Call Insights
- Strong Financial Performance: Ingevity reported total sales of $1.3 billion for 2025, an 8% decline year-over-year, yet adjusted gross profit reached $556 million, with adjusted EBITDA growing 10% to $398 million and EBITDA margin expanding to 30.8%, demonstrating the company's ability to maintain profitability amid challenges.
- Cash Flow and Shareholder Returns: The company achieved free cash flow of $274 million, the highest in five years, exceeding expectations, and successfully repurchased over 1 million shares, reducing net leverage to 2.6x, indicating a proactive strategy in capital returns and debt management.
- Optimistic Future Outlook: Ingevity expects adjusted EPS for 2026 to range between $4.08 and $5.20, with sales projected between $1.1 billion and $1.2 billion and adjusted EBITDA between $380 million and $400 million, reflecting a positive outlook despite no significant recovery in the global economy.
- Strategic Adjustments and Asset Sales: The company is advancing the sale of Advanced Polymer Technologies and Road Markings, with management expressing encouragement regarding interest in these assets, and updates are expected by year-end, further optimizing the asset portfolio to enhance market competitiveness.
See More
Ingevity Reports Q4 Earnings with Revenue Decline
- Poor Earnings Report: Ingevity's Q4 GAAP EPS stands at -$2.37, indicating significant challenges in profitability and reflecting pressure in market competition.
- Revenue Decline: The reported revenue of $278 million represents a 7.0% year-over-year decrease, suggesting that product demand may be impacted by changing market conditions, potentially leading to future cash flow pressures.
- Leadership Transition: The resignation of Ingevity's finance chief could affect the company's financial strategy and investor confidence, especially at a critical time when the company faces financial challenges.
- Strategic Portfolio Update: The company mentioned plans for a strategic portfolio update in its earnings report, aiming to optimize resource allocation and enhance market competitiveness to address current market challenges.
See More
Ingevity Announces Q4 and Full Year 2025 Earnings Release Date
- Earnings Release Schedule: Ingevity Corporation will release its fourth quarter and full year 2025 earnings after market close on February 25, 2026, reflecting the company's commitment to transparency and investor communication.
- Live Webcast: The company will host a live webcast on February 26, 2026, at 10:00 a.m. (Eastern), allowing participants to access the event via the investors section of Ingevity's website, enhancing engagement with investors.
- Conference Call Access: Participants can dial 833 470 1428 (inside the U.S.) and enter access code 102386 to join the conference call, demonstrating the company's effort to provide convenient communication channels for global investors.
- Financial Information Availability: Following the earnings release, a slide deck containing relevant financial and statistical information will be posted on the company's website, ensuring investors can access key information promptly, reflecting the company's commitment to information transparency.
See More
Ingevity Completes $110 Million Sale of North Charleston CTO Refinery Assets
- Asset Sale Completion: Ingevity has finalized the sale of its North Charleston Crude Tall Oil refinery assets and the majority of its Performance Chemicals Industrial Specialties product line for $110 million, with an additional potential contingent consideration of up to $19 million, aimed at simplifying its business structure and focusing on high-margin specialty applications.
- Strategic Restructuring: This transaction marks a significant step in Ingevity's strategic plan outlined during its December 8 investor event, as the company exits its remaining CTO product lines to concentrate on higher-margin businesses like activated carbon and pavement technologies, thereby enhancing overall operational efficiency.
- Business Focus: By retaining its Pavement Technologies business and other lignin-based dispersant products, Ingevity ensures it can continue to offer a diverse product range while strengthening its competitive position in the specialty materials market, aligning with its long-term strategic objectives.
- Market Outlook: This transaction not only enhances the company's financial flexibility but also provides funding for future investments and innovations, further solidifying Ingevity's leadership in the sustainable materials sector.
See More
CHASM and Ingevity Strengthen Partnership with Licensing Agreement to Ensure Local CNT Supply Chain for EV Battery Gigafactories in North America and Europe
CHASM and Ingevity Partnership: CHASM Advanced Materials has signed a license agreement with Ingevity Corporation for the production of carbon nanotube (CNT) additives for batteries, enhancing their collaboration to support the EV battery industry in North America and Europe.
Technology Validation: CHASM's NTeC®-E CNT additives have been validated by Ingevity's labs and third-party testing, proving to be more conductive and offering better capacity retention compared to other commercial CNT products.
Supply Chain Security: The partnership aims to establish a reliable, domestically sourced CNT supply chain for the growing electric vehicle battery market, reducing reliance on overseas suppliers.
Innovative Applications: CHASM's CNT technology is designed for integration into various battery chemistries and other applications, contributing to advancements in safety, connectivity, and sustainability in multiple industries.
See More
EVR Research Acquires New Position in Ingevity
- New Investment Position: On February 17, 2026, EVR Research disclosed to the SEC that it initiated a new position in Ingevity by acquiring 100,000 shares worth $5.92 million, indicating strong confidence in the company.
- Asset Allocation Insight: The newly acquired shares represent 3.19% of EVR Research's reportable U.S. equity assets totaling $185.31 million, highlighting the fund's strategic emphasis on Ingevity within its portfolio.
- Strong Market Performance: As of now, Ingevity shares are priced at $68.56, reflecting a 56% increase over the past year, significantly outperforming the S&P 500's approximate 19% gain, showcasing its robust market position.
- Positive Industry Outlook: Ingevity's operations are closely tied to emissions standards, infrastructure spending, and industrial production, which are expected to perform well when economic momentum stabilizes, aligning with EVR Research's investment strategy and demonstrating confidence in future growth.
See More
Ingevity Corporation Q4 2025 Earnings Call Insights
- Strong Financial Performance: Ingevity reported total sales of $1.3 billion for 2025, an 8% decline year-over-year, yet adjusted gross profit reached $556 million, with adjusted EBITDA growing 10% to $398 million and EBITDA margin expanding to 30.8%, demonstrating the company's ability to maintain profitability amid challenges.
- Cash Flow and Shareholder Returns: The company achieved free cash flow of $274 million, the highest in five years, exceeding expectations, and successfully repurchased over 1 million shares, reducing net leverage to 2.6x, indicating a proactive strategy in capital returns and debt management.
- Optimistic Future Outlook: Ingevity expects adjusted EPS for 2026 to range between $4.08 and $5.20, with sales projected between $1.1 billion and $1.2 billion and adjusted EBITDA between $380 million and $400 million, reflecting a positive outlook despite no significant recovery in the global economy.
- Strategic Adjustments and Asset Sales: The company is advancing the sale of Advanced Polymer Technologies and Road Markings, with management expressing encouragement regarding interest in these assets, and updates are expected by year-end, further optimizing the asset portfolio to enhance market competitiveness.
See More
Ingevity Reports Q4 Earnings with Revenue Decline
- Poor Earnings Report: Ingevity's Q4 GAAP EPS stands at -$2.37, indicating significant challenges in profitability and reflecting pressure in market competition.
- Revenue Decline: The reported revenue of $278 million represents a 7.0% year-over-year decrease, suggesting that product demand may be impacted by changing market conditions, potentially leading to future cash flow pressures.
- Leadership Transition: The resignation of Ingevity's finance chief could affect the company's financial strategy and investor confidence, especially at a critical time when the company faces financial challenges.
- Strategic Portfolio Update: The company mentioned plans for a strategic portfolio update in its earnings report, aiming to optimize resource allocation and enhance market competitiveness to address current market challenges.
See More
Ingevity Announces Q4 and Full Year 2025 Earnings Release Date
- Earnings Release Schedule: Ingevity Corporation will release its fourth quarter and full year 2025 earnings after market close on February 25, 2026, reflecting the company's commitment to transparency and investor communication.
- Live Webcast: The company will host a live webcast on February 26, 2026, at 10:00 a.m. (Eastern), allowing participants to access the event via the investors section of Ingevity's website, enhancing engagement with investors.
- Conference Call Access: Participants can dial 833 470 1428 (inside the U.S.) and enter access code 102386 to join the conference call, demonstrating the company's effort to provide convenient communication channels for global investors.
- Financial Information Availability: Following the earnings release, a slide deck containing relevant financial and statistical information will be posted on the company's website, ensuring investors can access key information promptly, reflecting the company's commitment to information transparency.
See More
Ingevity Completes $110 Million Sale of North Charleston CTO Refinery Assets
- Asset Sale Completion: Ingevity has finalized the sale of its North Charleston Crude Tall Oil refinery assets and the majority of its Performance Chemicals Industrial Specialties product line for $110 million, with an additional potential contingent consideration of up to $19 million, aimed at simplifying its business structure and focusing on high-margin specialty applications.
- Strategic Restructuring: This transaction marks a significant step in Ingevity's strategic plan outlined during its December 8 investor event, as the company exits its remaining CTO product lines to concentrate on higher-margin businesses like activated carbon and pavement technologies, thereby enhancing overall operational efficiency.
- Business Focus: By retaining its Pavement Technologies business and other lignin-based dispersant products, Ingevity ensures it can continue to offer a diverse product range while strengthening its competitive position in the specialty materials market, aligning with its long-term strategic objectives.
- Market Outlook: This transaction not only enhances the company's financial flexibility but also provides funding for future investments and innovations, further solidifying Ingevity's leadership in the sustainable materials sector.
See More
CHASM and Ingevity Strengthen Partnership with Licensing Agreement to Ensure Local CNT Supply Chain for EV Battery Gigafactories in North America and Europe
CHASM and Ingevity Partnership: CHASM Advanced Materials has signed a license agreement with Ingevity Corporation for the production of carbon nanotube (CNT) additives for batteries, enhancing their collaboration to support the EV battery industry in North America and Europe.
Technology Validation: CHASM's NTeC®-E CNT additives have been validated by Ingevity's labs and third-party testing, proving to be more conductive and offering better capacity retention compared to other commercial CNT products.
Supply Chain Security: The partnership aims to establish a reliable, domestically sourced CNT supply chain for the growing electric vehicle battery market, reducing reliance on overseas suppliers.
Innovative Applications: CHASM's CNT technology is designed for integration into various battery chemistries and other applications, contributing to advancements in safety, connectivity, and sustainability in multiple industries.
See More
